Maher Masoud

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ David Sandoval, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Maher Masoud:

Company Role Class Num Shares Value Price $ Report Date Ownership
MAXCYTE, INC. President and CEO, Director Common Stock 175,000 $240,135 $1.37 13 Aug 2025 Direct
MAXCYTE, INC. President and CEO, Director Employee Stock Option (right to buy) 347,500 14 Mar 2025 Direct

Insider Reports Filed by Maher Masoud

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MXCT MAXCYTE, INC. 13 Aug 2025 1 +$102,915 4 President and CEO, Director 13 Aug 2025, 19:47
MXCT MAXCYTE, INC. 14 Mar 2025 1 $0 4 President and CEO, Director 18 Mar 2025, 20:31
MXCT MAXCYTE, INC. 07 Jun 2024 2 +$489,066 4 President and CEO, Director 10 Jun 2024, 17:55
MXCT MAXCYTE, INC. 03 Jan 2024 1 $0 4 President and CEO, Director 04 Jan 2024, 16:30
MXCT MAXCYTE, INC. 20 Mar 2023 1 $0 4 EVP and General Counsel 21 Mar 2023, 16:43
MXCT MAXCYTE, INC. 25 Mar 2022 1 $0 4 EVP and General Counsel 29 Mar 2022, 16:21
MXCT MAXCYTE, INC. 12 Nov 2021 11 -$738,126 4 EVP and General Counsel 16 Nov 2021, 18:14
MXCT MAXCYTE, INC. 09 Aug 2021 1 $0 4 EVP and General Counsel 11 Aug 2021, 17:17
MXCT MAXCYTE, INC. 29 Jul 2021 0 $0 3 EVP and General Counsel 29 Jul 2021, 18:42